Nippon Life Global Investors Americas’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-70,380
Closed -$2.98M 143
2019
Q2
$2.98M Sell
70,380
-8,480
-11% -$368K 0.23% 103
2019
Q1
$3.9M Buy
78,860
+22,090
+39% +$999K 0.31% 89
2018
Q4
$2.46M Buy
56,770
+5,930
+12% +$296K 0.21% 103
2018
Q3
$2.89M Buy
50,840
+10,220
+25% +$538K 0.22% 101
2018
Q2
$2.05M Buy
+40,620
New +$2.12M 0.16% 123

Other funds holding GMED

Nippon Life Global Investors Americas's GMED Position: Q3 2019 in Review

Nippon Life Global Investors Americas sold out of Globus Medical (GMED) in Q3 2019, closing a stake of 70,380 shares — an estimated $2.98M sold.

Nippon Life Global Investors Americas first reported a position in GMED in Q2 2018 and held it in 5 quarters. The position peaked at $3.9M in Q1 2019. 268 funds tracked by Wall St. Rank hold GMED as of Q3 2019.

  • Nippon Life Global Investors Americas reported no remaining Globus Medical position as of Q3 2019 after selling out during the quarter.
  • Nippon Life Global Investors Americas sold 70,380 Globus Medical shares in Q3 2019, an estimated $2.98M.
  • Nippon Life Global Investors Americas first reported a position in Globus Medical in Q2 2018 and held it in 5 quarters.
  • Nippon Life Global Investors Americas's Globus Medical position peaked at $3.9M in Q1 2019.
  • 268 funds tracked by Wall St. Rank held Globus Medical as of Q3 2019.

Based on Nippon Life Global Investors Americas's 13F filing for Q3 2019, filed 21 Oct 2019.